Table of Content

1 Study Coverage
1.1 Peptide Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Peptide Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Parenteral Route of Administration
1.2.3 Mucosal Route of Administration
1.2.4 Oral Route of Administration
1.2.5 Transdermal Route of Administration
1.3 Market by Application
1.3.1 Global Peptide Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Gastrointestinal Disorders
1.3.5 Metabolic Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Peptide Therapy Sales Estimates and Forecasts 2018-2029
2.2 Global Peptide Therapy Revenue by Region
2.2.1 Global Peptide Therapy Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Peptide Therapy Revenue by Region (2018-2024)
2.2.3 Global Peptide Therapy Revenue by Region (2024-2029)
2.2.4 Global Peptide Therapy Revenue Market Share by Region (2018-2029)
2.3 Global Peptide Therapy Sales Estimates and Forecasts 2018-2029
2.4 Global Peptide Therapy Sales by Region
2.4.1 Global Peptide Therapy Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Peptide Therapy Sales by Region (2018-2024)
2.4.3 Global Peptide Therapy Sales by Region (2024-2029)
2.4.4 Global Peptide Therapy Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Peptide Therapy Sales by Manufacturers
3.1.1 Global Peptide Therapy Sales by Manufacturers (2018-2024)
3.1.2 Global Peptide Therapy Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peptide Therapy in 2022
3.2 Global Peptide Therapy Revenue by Manufacturers
3.2.1 Global Peptide Therapy Revenue by Manufacturers (2018-2024)
3.2.2 Global Peptide Therapy Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Peptide Therapy Revenue in 2022
3.3 Global Key Players of Peptide Therapy, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Peptide Therapy Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Peptide Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Peptide Therapy, Product Offered and Application
3.8 Global Key Manufacturers of Peptide Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peptide Therapy Sales by Type
4.1.1 Global Peptide Therapy Historical Sales by Type (2018-2024)
4.1.2 Global Peptide Therapy Forecasted Sales by Type (2024-2029)
4.1.3 Global Peptide Therapy Sales Market Share by Type (2018-2029)
4.2 Global Peptide Therapy Revenue by Type
4.2.1 Global Peptide Therapy Historical Revenue by Type (2018-2024)
4.2.2 Global Peptide Therapy Forecasted Revenue by Type (2024-2029)
4.2.3 Global Peptide Therapy Revenue Market Share by Type (2018-2029)
4.3 Global Peptide Therapy Price by Type
4.3.1 Global Peptide Therapy Price by Type (2018-2024)
4.3.2 Global Peptide Therapy Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Peptide Therapy Sales by Application
5.1.1 Global Peptide Therapy Historical Sales by Application (2018-2024)
5.1.2 Global Peptide Therapy Forecasted Sales by Application (2024-2029)
5.1.3 Global Peptide Therapy Sales Market Share by Application (2018-2029)
5.2 Global Peptide Therapy Revenue by Application
5.2.1 Global Peptide Therapy Historical Revenue by Application (2018-2024)
5.2.2 Global Peptide Therapy Forecasted Revenue by Application (2024-2029)
5.2.3 Global Peptide Therapy Revenue Market Share by Application (2018-2029)
5.3 Global Peptide Therapy Price by Application
5.3.1 Global Peptide Therapy Price by Application (2018-2024)
5.3.2 Global Peptide Therapy Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Peptide Therapy Market Size by Type
6.1.1 US & Canada Peptide Therapy Sales by Type (2018-2029)
6.1.2 US & Canada Peptide Therapy Revenue by Type (2018-2029)
6.2 US & Canada Peptide Therapy Market Size by Application
6.2.1 US & Canada Peptide Therapy Sales by Application (2018-2029)
6.2.2 US & Canada Peptide Therapy Revenue by Application (2018-2029)
6.3 US & Canada Peptide Therapy Market Size by Country
6.3.1 US & Canada Peptide Therapy Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Peptide Therapy Sales by Country (2018-2029)
6.3.3 US & Canada Peptide Therapy Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Peptide Therapy Market Size by Type
7.1.1 Europe Peptide Therapy Sales by Type (2018-2029)
7.1.2 Europe Peptide Therapy Revenue by Type (2018-2029)
7.2 Europe Peptide Therapy Market Size by Application
7.2.1 Europe Peptide Therapy Sales by Application (2018-2029)
7.2.2 Europe Peptide Therapy Revenue by Application (2018-2029)
7.3 Europe Peptide Therapy Market Size by Country
7.3.1 Europe Peptide Therapy Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Peptide Therapy Sales by Country (2018-2029)
7.3.3 Europe Peptide Therapy Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Peptide Therapy Market Size
8.1.1 China Peptide Therapy Sales (2018-2029)
8.1.2 China Peptide Therapy Revenue (2018-2029)
8.2 China Peptide Therapy Market Size by Application
8.2.1 China Peptide Therapy Sales by Application (2018-2029)
8.2.2 China Peptide Therapy Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Peptide Therapy Market Size by Type
9.1.1 Asia Peptide Therapy Sales by Type (2018-2029)
9.1.2 Asia Peptide Therapy Revenue by Type (2018-2029)
9.2 Asia Peptide Therapy Market Size by Application
9.2.1 Asia Peptide Therapy Sales by Application (2018-2029)
9.2.2 Asia Peptide Therapy Revenue by Application (2018-2029)
9.3 Asia Peptide Therapy Sales by Region
9.3.1 Asia Peptide Therapy Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Peptide Therapy Revenue by Region (2018-2029)
9.3.3 Asia Peptide Therapy Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Peptide Therapy Market Size by Type
10.1.1 Middle East, Africa and Latin America Peptide Therapy Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Peptide Therapy Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Peptide Therapy Market Size by Application
10.2.1 Middle East, Africa and Latin America Peptide Therapy Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Peptide Therapy Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Peptide Therapy Sales by Country
10.3.1 Middle East, Africa and Latin America Peptide Therapy Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Peptide Therapy Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Peptide Therapy Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Eli Lilly Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AstraZeneca Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Merck Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Ipsen
11.4.1 Ipsen Company Information
11.4.2 Ipsen Overview
11.4.3 Ipsen Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Ipsen Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ipsen Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Information
11.5.2 Novo Nordisk Overview
11.5.3 Novo Nordisk Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novo Nordisk Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novo Nordisk Recent Developments
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Information
11.6.2 Teva Pharmaceutical Industries Overview
11.6.3 Teva Pharmaceutical Industries Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Teva Pharmaceutical Industries Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Abbott Laboratories Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Sanofi Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 J & J
11.9.1 J & J Company Information
11.9.2 J & J Overview
11.9.3 J & J Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 J & J Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 J & J Recent Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Overview
11.10.3 Novartis Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Novartis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Takeda
11.11.1 Takeda Company Information
11.11.2 Takeda Overview
11.11.3 Takeda Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Takeda Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Takeda Recent Developments
11.12 Ferring
11.12.1 Ferring Company Information
11.12.2 Ferring Overview
11.12.3 Ferring Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Ferring Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ferring Recent Developments
11.13 AbbVie
11.13.1 AbbVie Company Information
11.13.2 AbbVie Overview
11.13.3 AbbVie Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 AbbVie Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 AbbVie Recent Developments
11.14 Heinis
11.14.1 Heinis Company Information
11.14.2 Heinis Overview
11.14.3 Heinis Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Heinis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Heinis Recent Developments
11.15 Hemmo
11.15.1 Hemmo Company Information
11.15.2 Hemmo Overview
11.15.3 Hemmo Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Hemmo Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Hemmo Recent Developments
11.16 Emcure Pharmaceutical
11.16.1 Emcure Pharmaceutical Company Information
11.16.2 Emcure Pharmaceutical Overview
11.16.3 Emcure Pharmaceutical Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Emcure Pharmaceutical Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Emcure Pharmaceutical Recent Developments
11.17 Cipla
11.17.1 Cipla Company Information
11.17.2 Cipla Overview
11.17.3 Cipla Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Cipla Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cipla Recent Developments
11.18 Gland Pharma
11.18.1 Gland Pharma Company Information
11.18.2 Gland Pharma Overview
11.18.3 Gland Pharma Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Gland Pharma Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Gland Pharma Recent Developments
11.19 Troikaa Pharmaceuticals
11.19.1 Troikaa Pharmaceuticals Company Information
11.19.2 Troikaa Pharmaceuticals Overview
11.19.3 Troikaa Pharmaceuticals Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Troikaa Pharmaceuticals Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Troikaa Pharmaceuticals Recent Developments
11.20 Biological E
11.20.1 Biological E Company Information
11.20.2 Biological E Overview
11.20.3 Biological E Peptide Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Biological E Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Biological E Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peptide Therapy Industry Chain Analysis
12.2 Peptide Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peptide Therapy Production Mode & Process
12.4 Peptide Therapy Sales and Marketing
12.4.1 Peptide Therapy Sales Channels
12.4.2 Peptide Therapy Distributors
12.5 Peptide Therapy Customers
13 Market Dynamics
13.1 Peptide Therapy Industry Trends
13.2 Peptide Therapy Market Drivers
13.3 Peptide Therapy Market Challenges
13.4 Peptide Therapy Market Restraints
14 Key Findings in The Global Peptide Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Peptide Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Parenteral Route of Administration
Table 3. Major Manufacturers of Mucosal Route of Administration
Table 4. Major Manufacturers of Oral Route of Administration
Table 5. Major Manufacturers of Transdermal Route of Administration
Table 6. Global Peptide Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Peptide Therapy Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Peptide Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Peptide Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Peptide Therapy Revenue Market Share by Region (2018-2024)
Table 11. Global Peptide Therapy Revenue Market Share by Region (2024-2029)
Table 12. Global Peptide Therapy Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Peptide Therapy Sales by Region (2018-2024) & (K Units)
Table 14. Global Peptide Therapy Sales by Region (2024-2029) & (K Units)
Table 15. Global Peptide Therapy Sales Market Share by Region (2018-2024)
Table 16. Global Peptide Therapy Sales Market Share by Region (2024-2029)
Table 17. Global Peptide Therapy Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Peptide Therapy Sales Share by Manufacturers (2018-2024)
Table 19. Global Peptide Therapy Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Peptide Therapy Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Peptide Therapy, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Peptide Therapy Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Peptide Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Peptide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapy as of 2022)
Table 25. Global Key Manufacturers of Peptide Therapy, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Peptide Therapy, Product Offered and Application
Table 27. Global Key Manufacturers of Peptide Therapy, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 30. Global Peptide Therapy Sales by Type (2024-2029) & (K Units)
Table 31. Global Peptide Therapy Sales Share by Type (2018-2024)
Table 32. Global Peptide Therapy Sales Share by Type (2024-2029)
Table 33. Global Peptide Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Peptide Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Peptide Therapy Revenue Share by Type (2018-2024)
Table 36. Global Peptide Therapy Revenue Share by Type (2024-2029)
Table 37. Peptide Therapy Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Peptide Therapy Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Peptide Therapy Sales by Application (2018-2024) & (K Units)
Table 40. Global Peptide Therapy Sales by Application (2024-2029) & (K Units)
Table 41. Global Peptide Therapy Sales Share by Application (2018-2024)
Table 42. Global Peptide Therapy Sales Share by Application (2024-2029)
Table 43. Global Peptide Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Peptide Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Peptide Therapy Revenue Share by Application (2018-2024)
Table 46. Global Peptide Therapy Revenue Share by Application (2024-2029)
Table 47. Peptide Therapy Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Peptide Therapy Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Peptide Therapy Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Peptide Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Peptide Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Peptide Therapy Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Peptide Therapy Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Peptide Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Peptide Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Peptide Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Peptide Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Peptide Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 62. Europe Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 63. Europe Peptide Therapy Sales by Type (2024-2029) & (K Units)
Table 64. Europe Peptide Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Peptide Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Peptide Therapy Sales by Application (2018-2024) & (K Units)
Table 67. Europe Peptide Therapy Sales by Application (2024-2029) & (K Units)
Table 68. Europe Peptide Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Peptide Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Peptide Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Peptide Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Peptide Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 74. Europe Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 75. China Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 76. China Peptide Therapy Sales by Type (2024-2029) & (K Units)
Table 77. China Peptide Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Peptide Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Peptide Therapy Sales by Application (2018-2024) & (K Units)
Table 80. China Peptide Therapy Sales by Application (2024-2029) & (K Units)
Table 81. China Peptide Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Peptide Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 84. Asia Peptide Therapy Sales by Type (2024-2029) & (K Units)
Table 85. Asia Peptide Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Peptide Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Peptide Therapy Sales by Application (2018-2024) & (K Units)
Table 88. Asia Peptide Therapy Sales by Application (2024-2029) & (K Units)
Table 89. Asia Peptide Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Peptide Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Peptide Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Peptide Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Peptide Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Peptide Therapy Sales by Region (2018-2024) & (K Units)
Table 95. Asia Peptide Therapy Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Peptide Therapy Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Peptide Therapy Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Peptide Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Peptide Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Peptide Therapy Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Peptide Therapy Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Peptide Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Peptide Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Peptide Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Peptide Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Peptide Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 109. Eli Lilly Company Information
Table 110. Eli Lilly Description and Major Businesses
Table 111. Eli Lilly Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Eli Lilly Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Eli Lilly Recent Developments
Table 114. AstraZeneca Company Information
Table 115. AstraZeneca Description and Major Businesses
Table 116. AstraZeneca Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. AstraZeneca Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. AstraZeneca Recent Developments
Table 119. Merck Company Information
Table 120. Merck Description and Major Businesses
Table 121. Merck Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Merck Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Merck Recent Developments
Table 124. Ipsen Company Information
Table 125. Ipsen Description and Major Businesses
Table 126. Ipsen Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Ipsen Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Ipsen Recent Developments
Table 129. Novo Nordisk Company Information
Table 130. Novo Nordisk Description and Major Businesses
Table 131. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Novo Nordisk Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Novo Nordisk Recent Developments
Table 134. Teva Pharmaceutical Industries Company Information
Table 135. Teva Pharmaceutical Industries Description and Major Businesses
Table 136. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Teva Pharmaceutical Industries Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Teva Pharmaceutical Industries Recent Developments
Table 139. Abbott Laboratories Company Information
Table 140. Abbott Laboratories Description and Major Businesses
Table 141. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Abbott Laboratories Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Abbott Laboratories Recent Developments
Table 144. Sanofi Company Information
Table 145. Sanofi Description and Major Businesses
Table 146. Sanofi Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Sanofi Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Sanofi Recent Developments
Table 149. J & J Company Information
Table 150. J & J Description and Major Businesses
Table 151. J & J Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. J & J Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. J & J Recent Developments
Table 154. Novartis Company Information
Table 155. Novartis Description and Major Businesses
Table 156. Novartis Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Novartis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Novartis Recent Developments
Table 159. Takeda Company Information
Table 160. Takeda Description and Major Businesses
Table 161. Takeda Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Takeda Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Takeda Recent Developments
Table 164. Ferring Company Information
Table 165. Ferring Description and Major Businesses
Table 166. Ferring Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Ferring Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Ferring Recent Developments
Table 169. AbbVie Company Information
Table 170. AbbVie Description and Major Businesses
Table 171. AbbVie Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. AbbVie Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. AbbVie Recent Developments
Table 174. Heinis Company Information
Table 175. Heinis Description and Major Businesses
Table 176. Heinis Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Heinis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Heinis Recent Developments
Table 179. Hemmo Company Information
Table 180. Hemmo Description and Major Businesses
Table 181. Hemmo Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Hemmo Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Hemmo Recent Developments
Table 184. Emcure Pharmaceutical Company Information
Table 185. Emcure Pharmaceutical Description and Major Businesses
Table 186. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Emcure Pharmaceutical Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Emcure Pharmaceutical Recent Developments
Table 189. Cipla Company Information
Table 190. Cipla Description and Major Businesses
Table 191. Cipla Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. Cipla Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. Cipla Recent Developments
Table 194. Gland Pharma Company Information
Table 195. Gland Pharma Description and Major Businesses
Table 196. Gland Pharma Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 197. Gland Pharma Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 198. Gland Pharma Recent Developments
Table 199. Troikaa Pharmaceuticals Company Information
Table 200. Troikaa Pharmaceuticals Description and Major Businesses
Table 201. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 202. Troikaa Pharmaceuticals Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 203. Troikaa Pharmaceuticals Recent Developments
Table 204. Biological E Company Information
Table 205. Biological E Description and Major Businesses
Table 206. Biological E Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 207. Biological E Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 208. Biological E Recent Developments
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Peptide Therapy Distributors List
Table 212. Peptide Therapy Customers List
Table 213. Peptide Therapy Market Trends
Table 214. Peptide Therapy Market Drivers
Table 215. Peptide Therapy Market Challenges
Table 216. Peptide Therapy Market Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Therapy Product Picture
Figure 2. Global Peptide Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Peptide Therapy Market Share by Type in 2022 & 2029
Figure 4. Parenteral Route of Administration Product Picture
Figure 5. Mucosal Route of Administration Product Picture
Figure 6. Oral Route of Administration Product Picture
Figure 7. Transdermal Route of Administration Product Picture
Figure 8. Global Peptide Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Peptide Therapy Market Share by Application in 2022 & 2029
Figure 10. Cancer
Figure 11. Cardiovascular Diseases
Figure 12. Gastrointestinal Disorders
Figure 13. Metabolic Disorders
Figure 14. Others
Figure 15. Peptide Therapy Report Years Considered
Figure 16. Global Peptide Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Peptide Therapy Revenue 2018-2029 (US$ Million)
Figure 18. Global Peptide Therapy Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Peptide Therapy Revenue Market Share by Region (2018-2029)
Figure 20. Global Peptide Therapy Sales 2018-2029 ((K Units)
Figure 21. Global Peptide Therapy Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Peptide Therapy Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Peptide Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Peptide Therapy Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Peptide Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Peptide Therapy Sales YoY (2018-2029) & (K Units)
Figure 27. China Peptide Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Peptide Therapy Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Peptide Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Peptide Therapy Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Peptide Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Peptide Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Peptide Therapy in the World: Market Share by Peptide Therapy Revenue in 2022
Figure 34. Global Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Peptide Therapy Sales Market Share by Type (2018-2029)
Figure 36. Global Peptide Therapy Revenue Market Share by Type (2018-2029)
Figure 37. Global Peptide Therapy Sales Market Share by Application (2018-2029)
Figure 38. Global Peptide Therapy Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Peptide Therapy Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Peptide Therapy Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Peptide Therapy Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Peptide Therapy Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Peptide Therapy Revenue Share by Country (2018-2029)
Figure 44. US & Canada Peptide Therapy Sales Share by Country (2018-2029)
Figure 45. U.S. Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Peptide Therapy Sales Market Share by Type (2018-2029)
Figure 48. Europe Peptide Therapy Revenue Market Share by Type (2018-2029)
Figure 49. Europe Peptide Therapy Sales Market Share by Application (2018-2029)
Figure 50. Europe Peptide Therapy Revenue Market Share by Application (2018-2029)
Figure 51. Europe Peptide Therapy Revenue Share by Country (2018-2029)
Figure 52. Europe Peptide Therapy Sales Share by Country (2018-2029)
Figure 53. Germany Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 54. France Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 58. China Peptide Therapy Sales Market Share by Type (2018-2029)
Figure 59. China Peptide Therapy Revenue Market Share by Type (2018-2029)
Figure 60. China Peptide Therapy Sales Market Share by Application (2018-2029)
Figure 61. China Peptide Therapy Revenue Market Share by Application (2018-2029)
Figure 62. Asia Peptide Therapy Sales Market Share by Type (2018-2029)
Figure 63. Asia Peptide Therapy Revenue Market Share by Type (2018-2029)
Figure 64. Asia Peptide Therapy Sales Market Share by Application (2018-2029)
Figure 65. Asia Peptide Therapy Revenue Market Share by Application (2018-2029)
Figure 66. Asia Peptide Therapy Revenue Share by Region (2018-2029)
Figure 67. Asia Peptide Therapy Sales Share by Region (2018-2029)
Figure 68. Japan Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 72. India Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Peptide Therapy Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Peptide Therapy Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Peptide Therapy Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Peptide Therapy Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Peptide Therapy Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Peptide Therapy Sales Share by Country (2018-2029)
Figure 79. Brazil Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Peptide Therapy Revenue (2018-2029) & (US$ Million)
Figure 84. Peptide Therapy Value Chain
Figure 85. Peptide Therapy Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed